High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$10.0M
$10,016,381
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
CEO
Other
|
2026-03-16 | $399,990 | M | Form 4 |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
CEO
Other
|
2026-03-16 | $99,985 | M | Form 4 |
|
DNTH
S
Dianthus Therapeutics, Inc. /DE/
Garcia Marino
• CEO
10b5-1 SellΔOwn -82.5%
2026-03-12
$5,355,360Whale
|
||||||
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
CEO
10b5-1 SellΔOwn -82.5%
|
2026-03-12 | $5,355,360Whale | S | Form 4 |
|
DNTH
S
Dianthus Therapeutics, Inc. /DE/
Garcia Marino
• CEO
10b5-1 SellΔOwn -92.1%
2026-03-12
$1,056,950Large
|
||||||
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
CEO
10b5-1 SellΔOwn -92.1%
|
2026-03-12 | $1,056,950Large | S | Form 4 |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
CEO
Other
|
2026-03-12 | $823,551 | M | Form 4 |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
CEO
10b5-1 Sell
|
2026-03-12 | $76,977 | S | Form 4 |
|
DNTH
S
Dianthus Therapeutics, Inc. /DE/
Garcia Marino
• CEO
10b5-1 SellΔOwn -18.2%
2026-03-12
$16,676
|
||||||
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
CEO
10b5-1 SellΔOwn -18.2%
|
2026-03-12 | $16,676 | S | Form 4 |
|
DNTH
S
Dianthus Therapeutics, Inc. /DE/
Garcia Marino
• CEO
10b5-1 SellΔOwn -35.4%
2026-03-12
$3,510,418Large
|
||||||
| DNTH |
Dianthus Therapeutics, Inc. /DE/
|
CEO
10b5-1 SellΔOwn -35.4%
|
2026-03-12 | $3,510,418Large | S | Form 4 |